Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Clements

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Arthritis and Rheumatism|April 1, 1984
Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritisR F Willkens, H J Williams, J R Ward, et al.
Clinical and Experimental Rheumatology|November 6, 2010
A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patientsH G Kim, D P Tashkin, P J Clements, et al.
Annals of the Rheumatic Diseases|September 26, 2007
Development of a provisional core set of response measures for clinical trials of systemic sclerosisD Khanna, D J Lovell, E Giannini, et al.
The Journal of Rheumatology|March 7, 1998
Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosisJ R Seibold, P J Clements, D E Furst, et al.
The European Respiratory Journal|March 31, 2010
Systemic sclerosis and bilateral lung transplantation: a single centre experienceR Saggar, D Khanna, D E Furst, et al.
Annals of Internal Medicine|February 1, 1994
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind studyF M Wigley, R A Wise, J R Seibold, et al.
Arthritis and Rheumatism|November 11, 1999
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosisP J Clements, W K Wong, E L Hurwitz, et al.
Arthritis and Rheumatism|June 12, 1999
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.
Annals of Internal Medicine|April 15, 1993
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)K J Bulpitt, P J Clements, P A Lachenbruch, et al.
Rheumatology (Oxford, England)|June 27, 2001
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trialD E Furst, P J Clements, W K Wong, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Arthritis and Rheumatism|April 1, 1984
Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritisR F Willkens, H J Williams, J R Ward, et al.
Clinical and Experimental Rheumatology|November 6, 2010
A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patientsH G Kim, D P Tashkin, P J Clements, et al.
Annals of the Rheumatic Diseases|September 26, 2007
Development of a provisional core set of response measures for clinical trials of systemic sclerosisD Khanna, D J Lovell, E Giannini, et al.
The Journal of Rheumatology|March 7, 1998
Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosisJ R Seibold, P J Clements, D E Furst, et al.
The European Respiratory Journal|March 31, 2010
Systemic sclerosis and bilateral lung transplantation: a single centre experienceR Saggar, D Khanna, D E Furst, et al.
Annals of Internal Medicine|February 1, 1994
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind studyF M Wigley, R A Wise, J R Seibold, et al.
Arthritis and Rheumatism|November 11, 1999
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosisP J Clements, W K Wong, E L Hurwitz, et al.
Arthritis and Rheumatism|June 12, 1999
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.
Annals of Internal Medicine|April 15, 1993
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)K J Bulpitt, P J Clements, P A Lachenbruch, et al.
Rheumatology (Oxford, England)|June 27, 2001
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trialD E Furst, P J Clements, W K Wong, et al.
Pageof 10